How many insider declarations does 이연제약 have?

이연제약 has filed 1 insider declaration with DART (FSS).

Who is the top reporting insider at 이연제약?

The top reporting insider at 이연제약 is 이연제약, based on the count of public filings.

What is the net insider buy vs sell volume on 이연제약?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

이

이연제약: management transactions · South Korea · DART (FSS)

DART:company-c98d13KR·DART (FSS)Mcap 197.7Bn€

AMF ↗

Browse the full management transaction log of 이연제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Market capitalisation: €197.7bn. The latest transaction was disclosed on 12 March 2026 — Other. Among the most active insiders: 이연제약. The full history is accessible without an account.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

0 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

11470.00 €

Income statement

Revenue145.93 Bn€

Gross profit38.23 Bn€26% margin

Net income−29.63 Bn€-20.3% margin

Balance sheet & cash

Market cap197.72 Bn€

Total debt216.12 Bn€

Free Cash Flow−6.46 Bn€

Last declaration on 12 March 2026

All Executives1 Thresholds Prospectus Other

Declarations1 total

Executives●Other0DART

DART:20260312000652·12 Mar 2026details not loaded

DART ↗

1 of 1 declaration